Cutlass Capital

Boston, United States
US healthcare companies are invested in stage-agnostically by Cutlass Capital.

About Cutlass Capital

Cutlass Capital is a company based in Boston (United States). US healthcare companies are invested in stage-agnostically by Cutlass Capital. It operates on a B2B model.

Company details

A stage-agnostic venture capital firm, Cutlass Capital, is based in Boston, United States. Investments are directed toward US companies in the healthcare sector, particularly life sciences areas such as diagnostics and medical devices. More than 57 million in committed capital is managed by the firm. The portfolio encompasses companies including Alere Medical, Byram Holdings, Xoft, and Titan Health.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cutlass Capital

Cutlass Capital is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

A stage-agnostic venture capital firm, Cutlass Capital, is based in Boston, United States. Investments are directed toward US companies in the healthcare sector, particularly life sciences areas such as diagnostics and medical devices. More than 57 million in committed capital is managed by the firm. The portfolio encompasses companies including Alere Medical, Byram Holdings, Xoft, and Titan Health.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available